Akademik Veri Yönetim Sistemi
19. ULUSAL DERMATOLOJİ KONGRESİ, Antalya, Türkiye, 2 Temmuz - 07 Eylül 2002, cilt.43, (Yayınlanmadı)
Background Systemic antibiotics currently used in the treatment of rosacea are sometimes associated with uncomfortable side-effects. Therefore, a need for an effective agent with few side-effects and good patient compliance exists. Azithromycin, a macrolide antibiotic with prolonged mode of action, has recently been found to be an effective alternative in the treatment of inflammatory acne. We planned a study to evaluate the efficacy and safety of azithromycin in rosacea.